These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30936736)

  • 1. Interactive and potentially independent roles of renin-angiotensin-aldosterone system blockade and the development of cardiorenal syndrome type 1 on in-hospital mortality among elderly patients admitted with acute decompensated congestive heart failure.
    Iglesias J; Ghetiya S; Ledesma KJ; Patel CS; Levine JS
    Int J Nephrol Renovasc Dis; 2019; 12():33-48. PubMed ID: 30936736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors and Prognosis of Cardiorenal Syndrome Type 1 in Elderly Chinese Patients: A Retrospective Observational Cohort Study.
    Hu W; He W; Liu W; Fang X; Wu Y; Yu F; Hao W
    Kidney Blood Press Res; 2016; 41(5):672-679. PubMed ID: 27676190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival after hospitalization for acute heart failure--differences in prognosis of acutely decompensated chronic and new-onset acute heart failure.
    Lassus JP; Siirilä-Waris K; Nieminen MS; Tolonen J; Tarvasmäki T; Peuhkurinen K; Melin J; Pulkki K; Harjola VP;
    Int J Cardiol; 2013 Sep; 168(1):458-62. PubMed ID: 23073273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment and validation of a new predictive equation with multiple risk factors for the development of cardiorenal syndrome type 1 in patients with acute myocardial infarction].
    He CH; Liu JW; Zhu ZH; Pan HW; Zheng ZF; He J; Liu ZY; Zhang Y; Wang CL; Rong JJ; Tang Y; Zhang QH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Aug; 49(8):802-808. PubMed ID: 34404190
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence, Mortality and Positive Predictive Value of Type 1 Cardiorenal Syndrome in Acute Coronary Syndrome.
    Pimienta González R; Couto Comba P; Rodríguez Esteban M; Alemán Sánchez JJ; Hernández Afonso J; Rodríguez Pérez MD; Marcelino Rodríguez I; Brito Díaz B; Elosua R; Cabrera de León A
    PLoS One; 2016; 11(12):e0167166. PubMed ID: 27907067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of Plasma NGAL and Creatinine on First Day of Admission in the Diagnosis of Cardiorenal Syndrome Type 1.
    Phan Thai H; Hoang Bui B; Hoang Anh T; Huynh Van M
    Cardiol Res Pract; 2020; 2020():2789410. PubMed ID: 33083054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
    Bakris GL; Weir MR
    Arch Intern Med; 2000 Mar; 160(5):685-93. PubMed ID: 10724055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
    Mayyas F; Bataineh W; Jarab A
    Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors for Type 1 cardio-renal syndrome after ST-segment elevation myocardial infarction].
    Pan H; Guo Y; Zheng Z; Peng J; Zhang Y; He J; Liu Z; Hu Y; Wang C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 39(4):355-60. PubMed ID: 24820274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Acute Kidney Disease after an Episode of AKI: A Multicenter Prospective Cohort Study.
    Hines A; Li X; Ortiz-Soriano V; Saleh S; Litteral J; Ruiz-Conejo M; Wald R; Silver SA; Neyra JA
    Am J Nephrol; 2020; 51(4):266-275. PubMed ID: 32088714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors and Outcomes of Acute Cardio-renal Syndrome in a Tertiary Care Setting in South India.
    Fernando K; Parthasarathy R; Mathew M; Abraham G; Lesley N; Muruganathan A; Mullaseri A
    J Assoc Physicians India; 2021 Aug; 69(8):11-12. PubMed ID: 34472802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy.
    Steely AM; Callas PW; Bertges DJ;
    J Vasc Surg; 2016 Mar; 63(3):715-21. PubMed ID: 26603543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram Model to Predict Cardiorenal Syndrome Type 1 in Patients with Acute Heart Failure.
    Fan Z; Li Y; Ji H; Jian X
    Kidney Blood Press Res; 2018; 43(6):1832-1841. PubMed ID: 30537702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome.
    Palazzuoli A; Mancone M; De Ferrari GM; Forleo G; Secco GG; Ruocco GM; D'Ascenzo F; Monticone S; Paggi A; Vicenzi M; Palazzo AG; Landolina M; Taravelli E; Tavazzi G; Blasi F; Infusino F; Fedele F; De Rosa FG; Emmett M; Schussler JM; Tecson KM; McCullough PA
    J Am Heart Assoc; 2020 Nov; 9(22):e017364. PubMed ID: 33023356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential actions of vasopeptidase inhibition versus angiotensin-converting enzyme inhibition on diuretic therapy in experimental congestive heart failure.
    Cataliotti A; Boerrigter G; Chen HH; Jougasaki M; Costello LC; Tsuruda T; Lee SC; Malatino LS; Burnett JC
    Circulation; 2002 Feb; 105(5):639-44. PubMed ID: 11827932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of renin-angiotensin-aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study.
    Sato K; White N; Fanning JP; Obonyo N; Yamashita MH; Appadurai V; Ciullo A; May M; Worku ET; Helms L; Ohshimo S; Juzar DA; Suen JY; Bassi GL; Fraser JF; Arora RC;
    BMC Cardiovasc Disord; 2022 Mar; 22(1):123. PubMed ID: 35321649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure: invasive hemodynamic parameters and clinical outcomes.
    Lo KB; Toroghi HM; Salacup G; Jiang J; Bhargav R; Quintero E; Balestrini K; Shahzad A; Mathew RO; McCullough PA; Rangaswami J
    Rev Cardiovasc Med; 2021 Mar; 22(1):199-206. PubMed ID: 33792263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrolyte abnormalities and metabolic acidosis in two Duchenne muscular dystrophy patients with advanced congestive heart failure].
    Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
    Rinsho Shinkeigaku; 2000 May; 40(5):439-45. PubMed ID: 11002725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
    Trifirò G; Massari M; Da Cas R; Menniti Ippolito F; Sultana J; Crisafulli S; Giorgi Rossi P; Marino M; Zorzi M; Bovo E; Leoni O; Ludergnani M; Spila Alegiani S;
    Drug Saf; 2020 Dec; 43(12):1297-1308. PubMed ID: 32852721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.